ConductScience.org, home

Paper16630020

Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.

Weekes MP and 3 others. Immunology, 2006. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy. Papers, record 16630020. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16630020

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.
PubMed
Journal
Immunology
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2025-05-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weekes MPMichael P
2Wills MRMark R
3Sissons JGJ G Patrick
4Carmichael AJAndrew J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiretroviral Therapy, Highly ActiveMajor topic
HIV InfectionsMajor topic
T-Lymphocytes, CytotoxicMajor topic
Anti-HIV Agents
Clone Cells
Cytomegalovirus Infections
Epitopes, T-Lymphocyte
Gene Products, env
Gene Products, gag
Genes, MHC Class I
Humans
Immunologic Memory
Immunophenotyping
Phosphoproteins
T-Lymphocyte Subsets
Viral Matrix Proteins

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G9202171Medical Research CouncilUnited KingdomPubMed
G9800943Medical Research CouncilUnited KingdomPubMed
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19360926Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science1997https://conductscience.org/library/papers/9360926PubMed
210878387Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.J Immunol2000https://conductscience.org/library/papers/10878387PubMed
311920293Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection.J Infect Dis2002https://conductscience.org/library/papers/11920293PubMed
412023339Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response.J Immunol2002https://conductscience.org/library/papers/12023339PubMed
510438796
Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy.
J Virol1999https://conductscience.org/library/papers/10438796PubMed
611535496Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.Blood2001https://conductscience.org/library/papers/11535496PubMed
710756025Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.J Virol2000https://conductscience.org/library/papers/10756025PubMed
810353864Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.J Infect Dis1999https://conductscience.org/library/papers/10353864PubMed
99971792The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo.J Virol1999https://conductscience.org/library/papers/9971792PubMed
1011927944Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.Nat Med2002https://conductscience.org/library/papers/11927944PubMed
1110229228HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.Nat Med1999https://conductscience.org/library/papers/10229228PubMed
1210516022Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.J Virol1999https://conductscience.org/library/papers/10516022PubMed
1310358151Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells.J Immunol1999https://conductscience.org/library/papers/10358151PubMed
148207839Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.J Virol1994https://conductscience.org/library/papers/8207839PubMed
158920869Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis.J Exp Med1996https://conductscience.org/library/papers/8920869PubMed
1612505709A systematic comparison of methods to measure HIV-1 specific CD8 T cells.J Immunol Methods2003https://conductscience.org/library/papers/12505709PubMed
1712869514Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.Blood2003https://conductscience.org/library/papers/12869514PubMed
1810903781Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.J Immunol2000https://conductscience.org/library/papers/10903781PubMed
1911413318Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.J Virol2001https://conductscience.org/library/papers/11413318PubMed
2010358214Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.J Immunol1999https://conductscience.org/library/papers/10358214PubMed

See all 43 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
41460874Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study.PLoS Pathog2025https://conductscience.org/library/papers/41460874PubMed
39255323Antiviral capacity of the early CD8 T-cell response is predictive of natural control of SIV infection: Learning in vivo dynamics using ex vivo data.PLoS Comput Biol2024https://conductscience.org/library/papers/39255323PubMed
38943022Limited HIV-associated neuropathologies and lack of immune activation in sub-saharan African individuals with late-stage subtype C HIV-1 infection.J Neurovirol2024https://conductscience.org/library/papers/38943022PubMed
34988339Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART.Pathog Immun2021https://conductscience.org/library/papers/34988339PubMed
30405632Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection.Front Immunol2018https://conductscience.org/library/papers/30405632PubMed
23115277Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.J Virol2013https://conductscience.org/library/papers/23115277PubMed
22238642CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control.PLoS One2012https://conductscience.org/library/papers/22238642PubMed
21752903High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.J Virol2011https://conductscience.org/library/papers/21752903PubMed
17825804Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.Cell Immunol2007https://conductscience.org/library/papers/17825804PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
TRB6957PubTator's text mininghttps://conductscience.org/library/genes/6957NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16630020

GET https://conductscience.org/api/papers/v1/16630020/references?page=2